While HER2 amplification has been found to occur at the ADH stage, the morphologic stage that may represent the stage just after the early neoplasias profiled here [26], amplification is not likely to explain the increased transcript levels for the majority of the early neoplasias studied here. The gene discussed is ERBB2; the disease is neoplasm.